Photo of J Shannon Swan,  MD

J Shannon Swan, MD

Massachusetts General Hospital

Massachusetts General Hospital
Phone: (617) 726-7633
Fax: (617) 726-9414


shannon@mgh-ita.org

J Shannon Swan, MD

Massachusetts General Hospital

EDUCATIONAL TITLES

  • Associate Professor, Radiology, Harvard Medical School
  • Radiologist, Radiology, Massachusetts General Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

My work is focused on measurement of quality of life. I am interested in the usage of existing measures for measuring preference-based quality of life and also developing new measures. My work has previously emphasized the effects of diagnostic testing and screening, using both typical holistic measures and multiattribute utility techniques. I have recently extended my work into cancer. Working with MGH collaborators, I recently published an index for quality of life measurement in non-small cell lung cancer. This instrument is based on the FACT-L and is called the FACT-LUI. It has 7 items and can be calculated with 2 different measurement tradition approaches.

Publications

Powered by Harvard Catalyst
  • Lubitz CC, De Gregorio L, Fingeret AL, Economopoulos KP, Termezawi D, Hassan M, Parangi S, Stephen AE, Halpern EF, Donelan K, Swan JS. Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma. Thyroid 2016. PubMed
  • Tramontano AC, Schrag DL, Malin JK, Miller MC, Weeks JC, Swan JS, McMahon PM. Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study. Med Decis Making 2015; 35:371-87. PubMed
  • Swan JS, Kong CY, Hur C, Halpern EF, Itauma O, Williams O, Motazedi T, Lee JM. Comparing morbidities of testing with a new index: screening colonoscopy versus core-needle breast biopsy. J Am Coll Radiol 2015; 12:295-301. PubMed
  • Kong CY, Meng L, Omer ZB, Swan JS, Srouji S, Gazelle GS, Fennessy FM. MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis. AJR Am J Roentgenol 2014; 203:361-71. PubMed
  • Humphrey KL, Lee JM, Donelan K, Kong CY, Williams O, Itauma O, Halpern EF, Gerade BJ, Rafferty EA, Swan JS. Percutaneous breast biopsy: effect on short-term quality of life. Radiology 2014; 270:362-8. PubMed
  • Swan JS, Kong CY, Lee JM, Itauma O, Halpern EF, Lee PA, Vavinskiy S, Williams O, Zoltick ES, Donelan K. Patient and societal value functions for the testing morbidities index. Med Decis Making 2013; 33:819-38. PubMed
  • Carlos RC, Buist DS, Wernli KJ, Swan JS. Patient-centered outcomes in imaging: quantifying value. J Am Coll Radiol 2012; 9:725-8. PubMed
  • Fennessy FM, Kong CY, Tempany CM, Swan JS. Quality-of-life assessment of fibroid treatment options and outcomes. Radiology 2011. PubMed
  • Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O, Bihrle M, Maytal G, August M, Gazelle GS, Swan JS. Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist 2011; 16:121-32. PubMed
  • Swan JS, Ying J, Stahl J, Kong CY, Moy B, Roy J, Halpern E. Initial development of the Temporary Utilities Index: a multiattribute system for classifying the functional health impact of diagnostic testing. Qual Life Res 2010; 19:401-12. PubMed
  • Swan JS, Miksad RA. Measuring the quality-of-life effects of diagnostic and screening tests. J Am Coll Radiol 2009; 6:567-75. PubMed
  • Swan JS, Lawrence WF, Roy J. Process utility in breast biopsy. Med Decis Making 2006; 26:347-59. PubMed
  • Swan JS, Lennes IT, Stump NN, Temel JS, Wang D, Keller L, Donelan K. A Patient-Centered Utility Index for Non-Small Cell Lung Cancer in the United States. MDM Policy Pract 2018; 3:2381468318801565. PubMed
  • Swan JS, Hur C, Lee P, Motazedi T, Donelan K. Responsiveness of the testing morbidities index in colonoscopy. Value Health 2013; 16:1046-53. PubMed
Hide